Clinical development of galunisertib (LY2157299 monohydrate), a small molecule inhibitor of transforming growth factor-beta signaling pathway

• Main Authors: Herbertz S (Author), Sawyer JS (Author), Stauber AJ (Author), Gueorguieva I (Author), Driscoll KE (Author), Estrem ST (Author), Cleverly AL (Author), Desaiah D (Author), Guba SC (Author), Benhadji KA (Author), Slapak CA (Author), Lahn MM (Author)
• Format: Book
• Published: Dove Medical Press, 2015-08-01T00:00:00Z.
• Subjects: article
• Online Access: Connect to this object online.

Stephan Herbertz,1 J Scott Sawyer,2 Anja J Stauber,2 Ivelina Gueorguieva,3 Kyla E Driscoll,4 Shawn T Estrem,2 Ann L Cleverly,3 Durisala Desaiah,2 Susan C Guba,2 Karim A Benhadji,2 Christopher A Slapak,2 Michael M Lahn21Lilly Deutschland GmbH, Bad Homburg, Germany; 2Lilly Research Laboratori...